You Searched For "Regeneron Pharmaceuticals" and got 20 results
Sort By:
3 mins read
'Lies through her teeth every single day': Ron DeSantis hits back at Jen Psaki for comments about Florida schools
"Obviously they have got a lot of other problems, let's just be honest," DeSantis said of the Biden…
Kimberly Leonard
1 min read
Regeneron jumps 10% as Trump gets the drugmaker's antibody treatment
A team of SVB Leerink analysts said Regeneron's treatment could receive emergency use authorization…
Emily Graffeo
3 mins read
More patients want to join antibody drug trials after Trump's coronavirus treatment — though we don't know yet if it actually helps COVID-19
Trump was given Regeneron's antibody cocktail, which is not yet approved by regulators. He praised …
Sinéad Baker
3 mins read
One of Trump's COVID-19 treatments was developed using tissue that originally came from an abortion. He's tried to ban this kind of research.
Regeneron tested its antibodies with cells derived from an abortion in the Netherlands. The Trump a…
Sinéad Baker
1 min read
27 pharma execs involved in the hunt for COVID-19 vaccines have raked in more than $1 billion by selling stock this year. Here's who's cashed in the most from Regeneron, Moderna, Vir, and more.
A Business Insider analysis found 27 biotech insiders who had cashed in more than $10 million in st…
Andrew Dunn
3 mins read
Trump's experimental treatment from Regeneron puts the company in a 'very tough situation' as others request early access, CEO says
Trump was given early access to the experiment drug through "compassionate use," which requires bot…
Evan Sully
1 min read
Meet the billionaire doctors behind Regeneron, the pharmaceutical company that developed Trump's experimental COVID-19 treatment
Leonard Schleifer and George Yancopoulos, the leaders of the pharmaceutical giant Regeneron, built …
Taylor Nicole Rogers
5 mins read
Trump's doctors are targeting a 'sweet spot' in fighting COVID-19 by using experimental treatments early, but physicians caution the data is limited
"We are clearly in a data-free zone right here," an infectious-disease physician told Business Insi…
Andrew Dunn
1 min read
Regeneron widens its lead as the S&P 500's top performer after saying key COVID-19 drug may be available in the fall
Regeneron's antibody cocktail COVID-19 treatment is set to begin clinical trials over the summer, w…
Carmen Reinicke
6 mins read
A spate of advancements suggest new coronavirus treatments could be on the horizon — here's the latest
Potential therapies from pharma giant Eli Lilly and biotech company Regeneron saw promising trial r…
Aria Bendix
2 mins read
Inside the 3-decade rise of Regeneron — How much taxpayers spent on hydroxychloroquine — Walgreens' $1 billion bet on primary care
These are the top stories written by Business Insider's healthcare team for July 9.
Lydia Ramsey Pflanzer
2 mins read
US's Pfizer COVID-19 vaccine protective against Beta, Gamma variant of Coronavirus, according to study
The study, published in the journal mBio, also found that monoclonal antibody cocktail consi…
3 mins read
A billionaire pharma exec close to Andrew Cuomo also got priority access to early COVID-19 tests, report says
NY state officials gave Regeneron president George Yancopoulos COVID-19 tests last March, when test…
Alexandra Ma
1 min read
Scammers set up fake websites posing as COVID-19 treatments to trick people into sharing personal information, US officials warn
COVID-19-related fraud has proliferated in the past year, with Americans losing over $211 million t…
Aaron Holmes
2 mins read
Regeneron CEO says Trump's experience with the company's COVID-19 drug is the 'weakest evidence you can get' of whether it works
Regeneron's CEO says President Donald Trump's use of REGN-COV2 is just one case study and doesn't p…
Barbara Smith
2 mins read
What to know about Trump's coronavirus treatment regimen
These are Business Insider's biggest healthcare stories for October 5.
Lydia Ramsey Pflanzer
4 mins read
The FDA has authorized pills to treat COVID-19, replenishing the tool kit of treatments against Omicron
The FDA on Thursday authorized Merck's antiviral pill, one day after authorizing Pfizer's pill.
Andrew Dunn,Allison DeAngelis
5 mins read
Omicron has drug companies preparing for the worst. Here are their plans to counterattack the newest COVID-19 variant.
Experts fear that the newest variant may make vaccines and therapies less effective. "On the face o…
Andrew Dunn
4 mins read
Merck is set to make billions off a COVID-19 pill that could change the pandemic. Here's why some countries will pay more than others.
Merck's antiviral has not yet been authorized, but the company already has plans to distribute the …
Andrew Dunn
7 mins read
10 surprises that could rock biotech stocks in 2020, from a Regeneron acquisition, to big sales for key drugs on the cusp of launching
One approach that has caught attention is the link between responses to treatments and the microbio…